Citigroup’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-110,134
Closed -$4.15M 5838
2021
Q1
$4.15M Buy
110,134
+102,686
+1,379% +$3.87M ﹤0.01% 1446
2020
Q4
$127K Buy
7,448
+6,093
+450% +$104K ﹤0.01% 3525
2020
Q3
$6K Sell
1,355
-2,510
-65% -$11.1K ﹤0.01% 4609
2020
Q2
$24K Sell
3,865
-6,428
-62% -$39.9K ﹤0.01% 4153
2020
Q1
$23K Buy
10,293
+3,445
+50% +$7.7K ﹤0.01% 4308
2019
Q4
$31K Sell
6,848
-28,902
-81% -$131K ﹤0.01% 4291
2019
Q3
$139K Buy
35,750
+17,336
+94% +$67.4K ﹤0.01% 3282
2019
Q2
$111K Buy
18,414
+4,963
+37% +$29.9K ﹤0.01% 3563
2019
Q1
$180K Sell
13,451
-126,424
-90% -$1.69M ﹤0.01% 3201
2018
Q4
$1.3M Buy
139,875
+86,347
+161% +$803K ﹤0.01% 1834
2018
Q3
$745K Buy
53,528
+33,741
+171% +$470K ﹤0.01% 2216
2018
Q2
$313K Sell
19,787
-1,266
-6% -$20K ﹤0.01% 2642
2018
Q1
$362K Sell
21,053
-49,614
-70% -$853K ﹤0.01% 2515
2017
Q4
$1.55M Buy
70,667
+45,035
+176% +$987K ﹤0.01% 1624
2017
Q3
$1.05M Sell
25,632
-20,599
-45% -$843K ﹤0.01% 1903
2017
Q2
$1.39M Buy
46,231
+13,959
+43% +$420K ﹤0.01% 1729
2017
Q1
$1.17M Sell
32,272
-70,396
-69% -$2.55M ﹤0.01% 1806
2016
Q4
$5.15M Buy
102,668
+86,633
+540% +$4.34M ﹤0.01% 1026
2016
Q3
$842K Buy
16,035
+6,283
+64% +$330K ﹤0.01% 2069
2016
Q2
$403K Sell
9,752
-14,134
-59% -$584K ﹤0.01% 2381
2016
Q1
$970K Buy
23,886
+12,698
+113% +$516K ﹤0.01% 2099
2015
Q4
$465K Sell
11,188
-27,918
-71% -$1.16M ﹤0.01% 2401
2015
Q3
$602K Buy
39,106
+25,783
+194% +$397K ﹤0.01% 2075
2015
Q2
$331K Sell
13,323
-76,736
-85% -$1.91M ﹤0.01% 2425
2015
Q1
$2.06M Buy
90,059
+75,767
+530% +$1.73M ﹤0.01% 1328
2014
Q4
$386K Buy
14,292
+6,867
+92% +$185K ﹤0.01% 2657
2014
Q3
$87K Sell
7,425
-2,369
-24% -$27.8K ﹤0.01% 3267
2014
Q2
$152K Sell
9,794
-875
-8% -$13.6K ﹤0.01% 2788
2014
Q1
$210K Buy
10,669
+7,950
+292% +$156K ﹤0.01% 2826
2013
Q4
$46K Buy
+2,719
New +$46K ﹤0.01% 4199